|
|
1700 Perimeter Park Dr.
Morrisville, NC 27560-8404 USA
phone:(919) 862-1000
fax:(919) 862-1095
|
|
| Symbol |
SLXP |
| Exchange |
NASDAQ |
| Founded |
0 |
| Employees |
|
|
|
| www.salixpharm.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Pharma company licensing: gastrointestinal disorders |
|
| Management |
| Randy W. Hamilton, Founder; Lorin K. Johnson, Ph.D., Founder and Chief Scientific Liaison; John F. Chappell, Chairman of the Board; Thomas D'Alonzo, Director; Richard A. Franco, Sr., R.Ph., Director |
| |
|
|
|
|
|
|
|
| Keywords |
| pharmaceutical, gastrointestinal, ulcerative colitis, mesalamine, inflammatory |
|
|
|
| Description |
|
Salix is committed to being the leading U.S. specialty pharmaceutical company licensing, developing and marketing innovative products to healthcare professionals to prevent or treat gastrointestinal disorders. Their �search and development� efforts are designed to identify and acquire late-stage and/or marketed proprietary pharmaceutical products for the treatment of gastrointestinal disease that have an existing base of safety and efficacy data. This focus on late-stage products serves to reduce the risk, time and expense Salix invests in products compared to the investment typically associated with the research and early development phases of pharmaceutical products. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
